Inventor
BAO RUDI
CN21 patents
⚠️ This page may combine multiple inventors who share the name “BAO RUDI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
8 patentsUS11661437B2May 30, 2023
Steroid derivative regulators, method for preparing the same, and uses thereof
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD3 citations69
US10759782B2Sep 1, 2020
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD2 citations68
US12139508B2Nov 12, 2024
Steroid derivative regulators, method for preparing the same, and uses thereof
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD2 citations66
US11155534B2Oct 26, 2021
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD1 citations57
US11667631B2Jun 6, 2023
FGFR4 inhibitor, preparation method therefor, and applications thereof
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD0 citations48
US11608332B2Mar 21, 2023
FGFR4 inhibitor and preparation method and use thereof
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD0 citations48
US11136324B2Oct 5, 2021
Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD0 citations48
US11472882B2Oct 18, 2022
Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD0 citations46
CURIS INC
5 patentsUS9249156B2Feb 2, 2016
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC6 citations84
US9657032B2May 23, 2017
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC5 citations82
US10543197B2Jan 28, 2020
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC1 citations73
US11654136B2May 23, 2023
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC0 citations62
US11135205B2Oct 5, 2021
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC0 citations62
SHANGHAI HANSOH BIOMEDICAL CO LTD
5 patentsUS12466823B2Nov 11, 2025
Inhibitor containing bicyclic derivative, preparation method therefor and use thereof
SHANGHAI HANSOH BIOMEDICAL CO LTD1 citations62
US12540190B2Feb 3, 2026
Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereof
SHANGHAI HANSOH BIOMEDICAL CO LTD0 citations59
US10428081B2Oct 1, 2019
EGFR inhibitor, preparation method and use thereof
SHANGHAI HANSOH BIOMEDICAL CO LTD1 citations56
US10259820B2Apr 16, 2019
EGFR inhibitor, preparation method and use thereof
SHANGHAI HANSOH BIOMEDICAL CO LTD1 citations56
US12497396B2Dec 16, 2025
Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers
SHANGHAI HANSOH BIOMEDICAL CO LTD0 citations44
CAI XIONG
3 patentsUS8710219B2Apr 29, 2014
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CAI XIONG14 citations92
US8518910B2Aug 27, 2013
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
CAI XIONG2 citations62
US8119616B2Feb 21, 2012
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
CAI XIONG3 citations62